Xvivo Perfusion AB (publ) (STO:XVIVO)
Sweden
· Delayed Price · Currency is SEK 185.70
+6.80 (3.80%)
At close: Dec 5, 2025
Xvivo Perfusion AB Market Cap
Xvivo Perfusion AB has a market cap or net worth of 5.85 billion as of December 5, 2025. Its market cap has decreased by -58.92% in one year.
Market Cap
5.85B
Enterprise Value
5.69B
Revenue
813.59M
Ranking
n/a
PE Ratio
195.63
Stock Price
185.70
Market Cap Chart
Since October 8, 2012, Xvivo Perfusion AB's market cap has increased from 371.69M to 5.85B, an increase of 1,473.73%. That is a compound annual growth rate of 23.28%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Swedish Orphan Biovitrum AB | 113.39B |
| Getinge AB | 57.22B |
| Sectra AB | 52.91B |
| Camurus AB | 35.47B |
| Medicover AB | 35.04B |
| Asker Healthcare Group AB | 34.47B |
| BioArctic AB | 27.14B |
| AddLife AB | 21.92B |